Lumira Ventures
Lumira Ventures is a leading North American life sciences investment firm dedicated to advancing healthcare innovation and enhancing patient outcomes. The firm focuses on investing in transformative life sciences companies, partnering with mission-driven founders to deliver exceptional returns for investors. Lumira Ventures is committed to building companies that deliver impact to patients and healthcare systems worldwide, leveraging its experience and broad network to maximize the value, growth, and impact of its portfolio companies.
Lumira Ventures
141 Adelaide Street Suite 770 Toronto, ON Canada, M5H 3L5
What We Do
Lumira Ventures utilizes deep relationships within its network to facilitate due diligence and value-added processes, providing companies with incremental insights, tools, and opportunities needed to succeed.
The VIP program offers Ph.D., MBA, and MD students across Canada a unique opportunity to gain hands-on experience in life sciences venture capital and startups, nurturing the next generation of leaders.
Industry Focus
Portfolio
Endotronix focuses on heart failure management with its Cordella™ PA Sensor System, which has received FDA Premarket Approval.
#Medical Technology
HistoSonics is known for its Edison® Histotripsy System, a non-invasive tumor liquefying platform, which has received FDA clearance.
#Medical Technology
Aurinia Pharmaceuticals is known for LUPKYNIS™, a treatment for lupus nephritis, reducing the need for kidney transplants.
#Biopharmaceuticals
Zymeworks focuses on disruptive cancer therapies and has been supported by Lumira Ventures in its growth stages.
#Biopharmaceuticals
OpSens specializes in cardiology-focused medical devices and was acquired by Haemonetics for $345 million.
#Medical Devices
Congruence Therapeutics focuses on computational and experimental drug discovery for diseases of protein misfolding.
#Biotechnology
XyloCor Therapeutics is developing novel gene therapies for cardiovascular disease.
#Biopharmaceuticals
Cyrano Therapeutics is developing treatments for post-viral smell loss (hyposmia).
#Biopharmaceuticals
Cardiac Dimensions focuses on minimally invasive treatments for heart failure and related cardiovascular conditions.
#Medical Technology
AmacaThera develops advanced injectable biomaterials for oncology and pain therapeutics.
#Biotechnology
Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate.
#Medical Technology